Cognito has raised $105 million to develop its device to treat Alzheimer's disease. The company is currently waiting for the results of the test data. These data are intended to convince the US FDA to authorize the use of the device. The funding will support further research and the approval process. The device is intended for the therapy of patients with Alzheimer's disease. Cognito hopes for a positive verdict from the regulatory body based on clinical results.[7]